Varnas Saulius, Gu Xiaomeng, Metcalfe Andrew
Carl Zeiss Vision Australia Holdings Ltd., 1284 South Rd., MAB G13/6 MAB Eastern Promenade, Tonsley, SA 5042, Australia.
School of Mathematical Sciences, University of Adelaide, North Terrace, Adelaide, SA 5005, Australia.
J Clin Med. 2021 Feb 12;10(4):730. doi: 10.3390/jcm10040730.
The aim of this study is to provide reliable guidelines for the mean percentage efficacy together with the 95% credibility interval in slowing down progression of myopia by a specific intervention over defined time periods, derived from a substantial number of randomised controlled clinical trials (RCTs) with consistent outcomes. Multifocal spectacles and contact lenses represent interventions with the largest number of RCTs carried out. Our meta-analyses considered 10 RCTs involving 1662 children which have tested the efficacy of progressive addition spectacle lenses (PALs). In a separate model for comparison purposes nine RCTs with 982 children trialling soft multifocal contact lenses (MFCLs) were analysed. Bayesian random-effects hierarchical models were fitted. The highest efficacy in retarding progression of the scaled sphere equivalent refraction was achieved after 12 M follow-up with the mean 28% reduction in progression and the 95% credibility interval between 21% and 35%. For comparison, the 95% credibility interval for the mean efficacy of soft MFCLs at 12 M follow up is 21% to 37%. We conclude that both multifocal spectacle and contact lenses moderately slow down progression of myopia, relative to single-vision spectacle lenses (SVLs) in the first 12 months after intervention. The relative efficacy of PALs tends to weaken after the first 12 months.
本研究的目的是通过在特定时间段内进行的大量具有一致结果的随机对照临床试验(RCT),得出关于特定干预措施减缓近视进展的平均有效率以及95%可信区间的可靠指南。多焦点眼镜和隐形眼镜是进行RCT数量最多的干预措施。我们的荟萃分析纳入了10项涉及1662名儿童的RCT,这些试验测试了渐进多焦点眼镜片(PALs)的疗效。为了进行比较,在一个单独的模型中分析了9项涉及982名儿童的RCT,这些儿童试用了软性多焦点隐形眼镜(MFCLs)。拟合了贝叶斯随机效应分层模型。在随访12个月后,在延缓等效球镜度进展方面取得了最高疗效,平均进展减少28%,95%可信区间在21%至